4
Changes in Ownership
Atara Biotherapeutics, Inc. Filed Acc 0001209191-18-044412
Chief Executive Officer sold 7,800 shares at an average $38.00 ($296,432)
From the SEC's structured data for this filing
Trades in this filing
Ciechanover Isaac E. · Chief Executive Officer
Table I: Non-derivative
4 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2018-07-26 | Sale : show line 1 in the form | −3,800 | $39.02 | $148,276 | 93,878 | I |
| 2018-07-26 | Sale : show line 2 in the form | −100 | $39.45 | $3,945 | 93,778 | I |
| 2018-07-27 | Sale : show line 3 in the form | −2,200 | $36.55 | $80,410 | 91,578 | I |
| 2018-07-27 | Sale : show line 4 in the form | −1,700 | $37.53 | $63,801 | 89,878 | I |
| Open-market sales · 7,800 sh · avg $38.00 · $296,432 | ||||||
Loading xslF345X03/doc4.xml…